CC
TMCI icon

Centiva Capital’s Treace Medical Concepts TMCI Stock Holding History

Centiva Capital’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78K Sell
19,593
-8,718
-31% -$24K ﹤0.01% 1560
2026
Q1 		$37.9K Buy
+28,311
New +$56.4K ﹤0.01% 1514
2024
Q3 		– Sell
-27,036
Closed -$180K – 2598
2024
Q2 		$180K Buy
+27,036
New +$218K ﹤0.01% 1716

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Centiva Capital's TMCI Position: Q2 2026 in Review

Centiva Capital reduced its Treace Medical Concepts (TMCI) stake by 31% in Q2 2026, selling an estimated $24K and leaving 19,593 shares worth $78K. The position accounts for ﹤0.01% of the portfolio, ranked #1560.

Centiva Capital first reported a position in TMCI in Q2 2024 and has held it in 3 quarters since. The position peaked at $180K in Q2 2024. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Centiva Capital held 19,593 shares of Treace Medical Concepts worth $78K as of Q2 2026.
  • Centiva Capital sold 8,718 Treace Medical Concepts shares in Q2 2026, an estimated $24K.
  • Treace Medical Concepts made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1560 holding.
  • Centiva Capital first reported a position in Treace Medical Concepts in Q2 2024 and has held it in 3 quarters since.
  • Centiva Capital's Treace Medical Concepts position peaked at $180K in Q2 2024.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.